Veerhealth Care Ltd. Achieves Successful Closure of USFDA Inspection, Poised for Global Expansion

Veerhealth Care Ltd. has announced the successful closure of a USFDA inspection under 21 CFR 20.64(d)(3), paving the way for the export of USFDA-approved drug (OTC) products to the USA and other potential markets. The company underwent a renovation and upgrade of its manufacturing facility to meet USFDA standards, which impacted production but is now operating at full capacity. This development is expected to significantly boost the company's revenue and PAT, and it already supplies to a leading institutional supplier in the USA. Veerhealth Care is also aggressively working towards manufacturing and exports of products under the medical device category in the US.